Fortress Biotech Inc (FBIO)
Fortress Biotech is a biopharmaceutical company focused on acquiring, developing and commercializing pharmaceutical and biotechnology products and product candidates. Through its partner company, Co. markets dermatology products including Qbrexza®, which is a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane® (isotretinoin) capsule, which is an oral retinoid indicated for the treatment of severe recalcitrant nodular acne; as well as Ximino® (minocycline hydrochloride) extended release capsule, which is a tetracycline-class drug indicated to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris.
Preferred: FBIOP
![]()
![]() |
![]() ![]() |

![]() ![]() |
![]() ![]() |
![]() ![]() Get Dividend Alerts ![]() Get SEC Filing Alerts ![]() ![]() |
![]() Strong Buy (4.00 out of 4) 89th percentile
(ranked higher than approx. 89% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com ![]() |
![]() ![]() |